Blank Rome Represents Think Equity in Connection with $26.25M Initial Public Offering of Lantern Pharma Inc. Common Stock
Blank Rome represented Think Equity as representative of the underwriters in connection with a $26.25M initial public offering of Lantern Pharma Inc. common stock. Lantern is a clinical stage biotechnology company, focused on leveraging artificial intelligence (“A.I.”), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from our targeted oncology therapies. The transaction closed on June 15, 2020.